Ocular Toxicities Associated with ADCs and Other Cancer Therapies: Part 2 — An Interview with Dr Neel Pasricha on Adverse Event Management

Research To Practice | Oncology Videos · Sep 16, 2025 · 54m

Featuring an interview with Dr Neel Pasricha, including the following topics:

Anatomy and physiology of the cornea; intersection of ophthalmology and oncology for patients receiving antibody-drug conjugates (ADCs) (0:00)

Association of corneal toxicities with ADCs (4:56)

Dose and schedule modifications to mitigate ocular toxicities associated with belantamab mafodotin and other ADCs (9:02)

Spectrum and severity of corneal toxicities associated with datopotamab deruxtecan (14:44)

Role of optometrists and ophthalmologists in screening for and management of ocular toxicities (17:55)

Other ocular…